Pathstone Holdings’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.7M Sell
2025
Q2
$1.74M Buy
2025
Q1
$779K Buy
2024
Q4
$256K Sell
2024
Q3
$623K Buy
2024
Q2
$515K Buy
2024
Q1
$591K Buy
2023
Q4
$352K Buy